News

Qilu Pharma Announces Launch of a Generic Version of Cialis ® in the United States

ABOUT US

News

Qilu Pharma Announces Launch of a Generic Version of Cialis ® in the United States

Release time：

2019-03-06

March 26, 2019—Qilu Pharmaceutical today announced the U.S. approval and launch of Tadalafil Tablets, which makes the first Day 181 launched oral product for Qilu in US. Up to now, Qilu has launched twelve products in US and among them, ten products are the injectables.

Tadalafil Tablet is manufactured by its subsidiary Qilu Pharmaceutical (Hainan), which makes 1-2 products launched in US since 2016.

Qilu Pharma Announces Launch of a Generic Version of Vesicare® in the United States

Piperacillin Sodium/Tazobactam Sodium exported to US

Related News

Qilu Launches First Generic Version of Invega Sustenna® (Paliperidone Palmitate Suspension for Injection) in China

2023-10-12

Qilu Pharmaceutical launched the first innovative drug in China

2023-09-01

Qilu Pharmaceutical Group Awarded as Socially Responsible Enterprises (Entrepreneurs) in 2022

2023-04-04

Qilu Pharmaceutical ranks No.5 in the list of "Top 100 Enterprises in Chinese Pharmaceutical Industry”

2022-12-19